Easing the Transition to the First Injectable for People with Type 2 Diabetes - Certificate of Completion
Consider weekly long-acting GLP-1RA options to improve wellbeing for people with T2D
CDEs play an instrumental role in helping persons with T2D transition to their first injectable therapy at the appropriate time. This involves effectively communicating physiological benefits of GLP-1RA treatment, as well as assisting in effectively navigating patient concerns, such as injection technique. Based on the individual needs of the patient, strategies to improve patient acceptability to injectable therapy and ongoing management can then be developed, thereby addressing any reasons for patient inertia that may be present.
This program has been endorsed by the Australian Diabetes Educators Association for 1.00 CPD point.
This interactive online learning activity is valued at 1Hour(s) of continuing education.
Marwan Obaid (
MBBS, BSc(Med), FRACP, MMed
Staff Specialist Endocrinologist
South Western Sydney Local Health District, NSW), Rachel Freeman (
APD, CDE, BHSc (Nut&Diet), MSc (Diabetes)
Professional Services Manager
Australian Diabetes Educators Association)